KalVista Pharmaceuticals, Inc.
KALV
DELAYED 1 MONTH

27 insider filings · Latest: Jun 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 27, 2026May 29 8:05 PMChristopher YeaCHIEF DEVELOPMENT OFFICER
Sale
33,800$26.78$905.2K229,918(D)

View →

May 26, 2026May 27 8:05 PMChristopher YeaCHIEF DEVELOPMENT OFFICER
Sale
1,966$26.78$52.6K229,918(D)

View →

May 26, 2026May 27 8:05 PMNicole SweenyChief Commercial Officer
Sale
1,489$26.78$39.9K59,291(D)

View →

May 26, 2026May 27 8:05 PMPaul K. AudhyaCHIEF MEDICAL OFFICER
Sale
2,239$26.78$60.0K150,260(D)

View →

May 22, 2026May 26 11:35 PMBenjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER
Sale
10,926$26.78$292.6K479,989(D)

View →

May 22, 2026May 26 11:34 PMNicole SweenyChief Commercial Officer
Sale
1,861$26.78$49.8K55,780(D)

View →

May 22, 2026May 26 11:33 PMChristopher YeaCHIEF DEVELOPMENT OFFICER
Sale
2,358$26.78$63.2K228,759(D)

View →

May 22, 2026May 26 11:33 PMPaul K. AudhyaCHIEF MEDICAL OFFICER
Sale
2,685$26.78$71.9K147,499(D)

View →

May 22, 2026May 26 11:32 PMBrian PiekosChief Financial Officer
Sale
1,489$26.78$39.9K21,661(D)

View →

May 18, 2026May 19 8:05 PMChristopher YeaCHIEF DEVELOPMENT OFFICER
Sale
1,108$26.76$29.7K227,367(D)

View →

May 18, 2026May 19 8:04 PMPaul K. AudhyaCHIEF MEDICAL OFFICER
Sale
1,032$26.76$27.6K143,934(D)

View →

May 18, 2026May 19 8:03 PMBenjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER
Sale
1,129$26.76$30.2K467,665(D)

View →

May 12, 2026May 13 8:25 PMBenjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER
Sale
3,322$26.71$88.7K466,375(D)

View →

Mar 9, 2026Mar 10 10:47 PMBenjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER
Sale
6,693$16.08$107.6K451,815(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 11, 2026Jun 11 8:41 PMNancy StuartDirector
Disposition
74,000$34.270(D)

View →

Jun 11, 2026Jun 11 8:40 PMBrian JG PereiraDirector
Disposition
91,000$17.950(D)

View →

Jun 11, 2026Jun 11 8:38 PMWilliam FaireyDirector
Disposition
57,000$12.050(D)

View →

Jun 11, 2026Jun 11 8:37 PMPaul K. AudhyaCHIEF MEDICAL OFFICER
Disposition
328,300$24.970(D)

View →

Jun 11, 2026Jun 11 8:36 PMBethany SensenigDirector
Disposition
45,000$12.050(D)

View →

Jun 11, 2026Jun 11 8:33 PMPatrick TreanorDirector
Disposition
67,000$12.050(D)

View →

Jun 11, 2026Jun 11 8:32 PMNicole SweenyChief Commercial Officer
Disposition
302,500$9.510(D)

View →

Jun 11, 2026Jun 11 8:31 PMBilal ArifChief Operations Officer
Disposition
149,000$11.490(D)

View →

Jun 11, 2026Jun 11 8:30 PMLaurence ReidDirector
Disposition
17,000$10.070(D)

View →

Jun 11, 2026Jun 11 8:29 PMEdward W UnkartDirector
Disposition
109,000$22.650(D)

View →

Jun 11, 2026Jun 11 8:27 PMBenjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER
Disposition
1,444,034$25.950(D)

View →

Jun 11, 2026Jun 11 8:26 PMChristopher YeaCHIEF DEVELOPMENT OFFICER
Disposition
410,170$25.950(D)

View →

Jun 11, 2026Jun 11 8:25 PMBrian PiekosChief Financial Officer
Disposition
248,750$11.870(D)

View →

May 27, 2026May 29 8:05 PMChristopher YeaCHIEF DEVELOPMENT OFFICER
Option Exercise
33,800$7.070(D)

View →

May 22, 2026May 27 8:05 PMChristopher YeaCHIEF DEVELOPMENT OFFICER
Option Exercise
3,125—25,000(D)

View →

May 22, 2026May 27 8:05 PMNicole SweenyChief Commercial Officer
Option Exercise
5,000—40,000(D)

View →

May 22, 2026May 27 8:05 PMPaul K. AudhyaCHIEF MEDICAL OFFICER
Option Exercise
5,000—40,000(D)

View →

May 21, 2026May 26 11:35 PMBenjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
23,250—255,750(D)

View →

May 21, 2026May 26 11:34 PMNicole SweenyChief Commercial Officer
Option Exercise
6,250—68,750(D)

View →

May 21, 2026May 26 11:33 PMChristopher YeaCHIEF DEVELOPMENT OFFICER
Option Exercise
3,750—41,250(D)

View →

Page 1 of 2

Next →